UM
Residential Collegefalse
Status已發表Published
Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2
Chen M.2; Zhou H.2; Cheng N.1; Qian F.2; Ye R.D.2
2014-12-01
Source PublicationImmunobiology
ISSN18783279 01712985
Volume219Issue:12Pages:916-923
Abstract

Serum amyloid A (SAA) is a major acute-phase protein and a precursor of amyloid A, the deposit of which leads to amyloidosis. Different alleles exist in SAA1, a predominant form of the human SAA gene family. Emerging evidence has shown correlations between these alleles and diseases including familiar Mediterranean fever and amyloidosis. However, it remains unclear how the proteins encoded by these SAA1 alleles act differently. Here we report the characterization of proteins encoded by SAA1.1, SAA1.3, and SAA1.5, in comparison to that encoded by SAA2.2, for their preference of the SAA receptors including formyl peptide receptor 2 (FPR2) and Toll-like receptor 2 (TLR2). SAA1.1 was more efficacious than SAA1.3 and SAA1.5 but equally efficacious to SAA2.2 in calcium mobilization and chemotaxis assays, which measure the activation of the G protein-coupled FPR2. In agreement with this, SAA1.1 and SAA2.2 induced more robust phosphorylation of ERK than SAA1.3 and SAA1.5. Only small differences were observed between the SAA1 proteins tested and SAA2.2 in TLR2-dependent NF-κB luciferase reporter assay. In comparison, SAA1.3 was most effective in stimulating ERK and p38 MAPK phosphorylation. Using bone marrow-derived macrophages from C57BL/10ScN (Tlr4lps-del) mice, we examined the SAA isoforms for their induction of selected pro- and anti-inflammatory cytokines. SAA1.3 was most potent in the induction of TNFα and IL-1rn, whereas SAA1.5 induced robust IL-10 expression. These results show differences of the SAA1 isoforms in their selectivity for the SAA receptors, which may affect their roles in modulating inflammation and immunity.

KeywordFormyl Peptide Receptors Inflammation Innate Immunity Polymorphism Serum Amyloid a Toll-like Receptors
DOI10.1016/j.imbio.2014.08.002
URLView the original
Language英語English
WOS IDWOS:000345541900003
Scopus ID2-s2.0-84990015575
Fulltext Access
Citation statistics
Document TypeJournal article
CollectionUniversity of Macau
Affiliation1.University of Illinois College of Medicine
2.Shanghai Jiao Tong University
Recommended Citation
GB/T 7714
Chen M.,Zhou H.,Cheng N.,et al. Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2[J]. Immunobiology, 2014, 219(12), 916-923.
APA Chen M.., Zhou H.., Cheng N.., Qian F.., & Ye R.D. (2014). Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2. Immunobiology, 219(12), 916-923.
MLA Chen M.,et al."Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2".Immunobiology 219.12(2014):916-923.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Chen M.]'s Articles
[Zhou H.]'s Articles
[Cheng N.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Chen M.]'s Articles
[Zhou H.]'s Articles
[Cheng N.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Chen M.]'s Articles
[Zhou H.]'s Articles
[Cheng N.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.